COVID-19 vaccines: The global dementia movement & how you can help
This 75-minute webinar will look at the ongoing development and distribution of COVID-19 vaccines and what this means for the global dementia community.
News & events
News, conferences, events, blogs and updates from across the field of dementia and the work of Alzheimer's Disease International.
Featured news and events
Global Perspective for February 2020
ADI's Global Perspective for February 2020 now available.
Roche to end DIAN-TU-001 study for rare Autosomnal dominant Alzheimer’s disease
Roche announces end of DIAN-TU-001 study after it failed to meets its primary endpoint in people who are affected by early onset Autosomal dominant Alzheimer’s disease.
China approves first drug for mild to moderate Alzheimer’s in 17 years
hinese Pharmaceutical Company Green Valley announces their drug Oligomannate (GV-971) has been granted conditional approval for the treatment of "mild to moderate Alzheimer's disease".
Biogen and Eisai announce plans to file for market approval of Alzheimer’s drug
Biogen and Eisai have announced they will file for market approval for an investigational treatment for early Alzheimer’s disease.
Dementia given high priority at G20 Health Ministers Meeting
Ahead of the G20 Health Ministers Meeting in Okayama, ADI’s Chief Executive Paola Barbarino and Noriyo Washizu of Alzheimer's Association Japan (AAJ) continue to work on progress made earlier in the year at the Osaka Summit.
ADI interviewed by major Japanese newspaper ahead of G20 meeting
Ahead of the G20 Health Ministers Meeting in Okayama, ADI Chief Executive Paola was interviewed by one of Japan's largest newspaper.
Spanish government launches national plan to tackle dementia
The Spanish Ministry of Health, Consumption and Social Welfare has announced that they have adopted a national dementia plan.
World’s largest dementia study reveals two thirds of people still incorrectly think dementia is a normal part of ageing, rather than a medical condition
Results from the world’s largest survey reveals that stigma around dementia is preventing people from seeking the information, advice, support and medical help.